Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis.

ANCA atherosclerosis cardiovascular risk eosinophilic granulomatosis with polyangiitis eosinophils intima–media thickness vasculitis

Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 02 2023
Historique:
received: 23 04 2022
accepted: 17 07 2022
pubmed: 22 7 2022
medline: 4 2 2023
entrez: 21 7 2022
Statut: ppublish

Résumé

Patients affected by eosinophilic granulomatosis with polyangiitis (EGPA) display an increased risk of atherothrombotic events compared with the general population. An increased frequency of subclinical markers of atherosclerosis has been observed in other ANCA-associated vasculitis, but no specific study focused on EGPA. We therefore evaluated subclinical atherosclerosis in EGPA patients and in a control population. Forty EGPA patients and 80 controls matched by age, sex and traditional cardiovascular risk factors underwent sonographic assessment of common carotid artery (CCA) intima-media thickness (IMT). The presence of plaques of the CCA was also investigated. The correlation between CCA-IMT and clinical and laboratory features was also assessed. Median CCA-IMT was significantly higher in EGPA patients compared with controls (P = 0.002). Also, the proportion of subjects with increased CCA-IMT and with presence of plaques was significantly higher among EGPA patients (P < 0.001 for both). Moreover, within the EGPA cohort, CCA-IMT tended to increase with disease duration (P = 0.034) and corticosteroid cumulative dose (P = 0.004). No significant associations were found between CCA-IMT, ANCA status, other clinical features and therapeutic regimens. Notably, the prevalence of traditional cardiovascular risk factors was comparable in patients with vs without an increased CCA-IMT. Ultrasound markers of subclinical atherosclerosis are increased in EGPA patients as compared with controls, independently of traditional cardiovascular risk factors.

Identifiants

pubmed: 35863050
pii: 6648113
doi: 10.1093/rheumatology/keac427
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

835-840

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Federica Bello (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Alessandra Bettiol (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Elena Silvestri (E)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Irene Mattioli (I)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Maria Letizia Urban (ML)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Adalgisa Palermo (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Matteo Mazzetti (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Danilo Malandrino (D)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Ilenia Calcaterra (I)

Department of Clinical Medicine and Surgery, Federico II University, Naples.

Augusto Vaglio (A)

Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', University of Florence, Florence.

Matteo Nicola Dario Di Minno (MND)

Department of Translational Medical Sciences, Federico II University, Naples, Italy.

Giacomo Emmi (G)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Domenico Prisco (D)

Department of Experimental and Clinical Medicine, University of Florence, Florence.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH